New Jersey Bill A5487 Threatens Sales of Creatine, Green Tea to Minors, Mandates Age Checks
New Jersey's proposed Assembly Bill A5487 seeks to ban specific weight loss and muscle-building supplements, including creatine and green tea extract, for minors, mandating retail age verification and imposing fines for non-compliance. This follows a trend of state-level restrictions challenging manufacturers and brand owners on product distribution and compliance costs.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
New Jersey Assembly Bill A5487 proposes to prohibit the sale of certain weight loss and muscle-building supplements to individuals under 18 years of age. The legislation specifically targets products containing ingredients such as creatine and green tea extract, among others. Retailers would be mandated to implement age verification protocols at the point of sale, with non-compliance incurring financial penalties. This initiative aligns with a broader pattern of state-level legislative proposals across the United States, often linked to the 'STRIPED' campaign, aimed at restricting youth access to specific dietary supplements.
The supplement industry has voiced significant opposition to these measures, citing a lack of robust scientific consensus linking these supplements to eating disorders, a primary justification for the proposed restrictions. Furthermore, industry bodies argue that existing federal regulations and responsible marketing practices adequately address concerns regarding youth consumption. The introduction of A5487 follows New York's precedent, which remains the only US state to have successfully enacted similar restrictive legislation concerning minor access to specific supplement categories.
At a federal level, legislative efforts, such as H.R. 7366, aim to preempt state-specific regulations by asserting federal oversight and preventing states from implementing stricter laws than those already established nationally. However, the progress and ultimate success of such preemption bills remain uncertain, leaving the industry exposed to a patchwork of state-level compliance challenges. This regulatory fragmentation demands agile strategic responses from manufacturers and brand owners operating within the US market.
What this means for United States
US manufacturers and brand owners must prepare for increasing compliance complexity and operational costs. New Jersey's A5487 will necessitate investment in age verification systems for retailers and could drive reformulation efforts or differentiated labelling for products sold in regulated states. Brands will see compressed margins due to new compliance burdens, potentially requiring increased Minimum Order Quantities (MOQs) to offset retailer costs. This trend creates a competitive threat for smaller brands less equipped to manage multi-state regulatory compliance and offers an opportunity for manufacturers with flexible production lines and robust regulatory intelligence teams to support brand partners in navigating these varied requirements.
Retailers in New Jersey will need to update their point-of-sale systems and employee training programmes to ensure strict age verification, facing fines for non-compliance. Brand owners should assess their US distribution channels, particularly online sales, to ensure adherence to state-specific age restrictions, regardless of the consumer's location. Ingredient suppliers may also see shifts in demand profiles for affected ingredients as brand owners adjust formulations for compliance.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.